- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04485689
The Effect of Capsaicin-induced Pain on Homeostatic Plasticity in Healthy Human Participants
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim of this study is to investigate the effect of capsaicin-induced pain on homeostatic plasticity.
A randomised crossover design will be used to evaluate the effect of capsaicin-induced pain on homeostatic plasticity using cathodal transcranial direct current stimulation (tDCS). Each participant will take part in four experimental sessions during which homeostatic plasticity and corticomotor excitability will be induced and measured in the left primary motor cortex. Participants will receive - in randomised order - capsaicin or placebo patch placed on the dorsal part of the right hand.
Each participant will attend four sessions, being two consecutive sessions separated by two weeks (i.e. wash-out period). During the experiment, participants will be seated comfortably with hands and arms at rest. First, the electromyography electrodes will be placed at the right first dorsal interosseous muscle to be used for assessing the corticomotor excitability by recordings of motor evoked potentials by transcranial magnetic stimulation (TMS) on the left primary motor cortex. Then, the cap for tDCS on the left primary motor cortex will be mounted. The optimal scalp position (hot spot) for TMS stimulation will be identified and marked with a pen on the cap for standardisation. A 5 x 7 cm capsaicin/placebo patch will be placed on participants' right hand. After 30 minutes of patch application, baseline measures of pain and motor-evoked potentials will be taken. Then, the homeostatic plasticity induction process will take place followed by motor-evoked potentials recordings every 15 minutes up to 45 minutes post protocol. Participants will be divided in 2 groups, one group will receive ice over the patch as to reduce pain intensity to minimum of 1 in a numeric rating scale; the other group will proceed without ice. Homeostatic plasticity will be induced and measured as previously described. The patch will be left in place for 24 hours, at which point participants will return to the laboratory and homeostatic plasticity will once again be induced and measured. After a wash-out period of two weeks, participants will go through an identical process but at this time with a different patch.
Homeostatic plasticity will be induced in the left primary motor cortex using tDCS applied for 7 minutes followed by an interval of 3 minutes and another block of 5 minutes of stimulation. A constant current of 2mA will be transmitted through the tDCS system, using two 25 cm2 electrodes placed into holes of a cap over the hot spot and right supraorbital area.
A sample size calculation was conducted using α of 0.05, β of 0.80 and effect size of 0.29 based on motor evoked potential (MEP) analysis of previous studies resulting in a target of 22 participants. To account for differences in designs 24 participants will be included, being 12 in each group.
Data distribution will be assessed using the Shapiro-Wilk test. A mixed analysis of variance (ANOVA) will be conducted on mean MEPs: within factors Intervention (Capsaicin and Placebo), Time (baseline, 0 min, 15 min, min, 30 min, 45 min), Time with pain (immediate, post pain relief post prolonged pain); and between factor (ice , no ice). A Greenhouse-Geisser correction will be used if Mauchly's test shows that sphericity cannot be assumed. Adjustments will be made for multiple post-hoc comparisons using the Bonferroni correction. Results will be interpreted according to the level of statistical significance p≤0.05.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aalborg, Denmark, 9220
- Recruiting
- Aalborg University
-
Contact:
- Priscilla G Wittkopf, PhD
- Phone Number: +4531539979
- Email: pgw@hst.aau.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy, aged between 18-60 years, right-handed and can speak and understand English.
Exclusion Criteria:
- Lack of ability to cooperate
- Chili allergy
- History or present chronic pain or current acute pain
- Pregnancy
- Drug addiction defined as the use of cannabis, opioids or other drugs
- Present and previous neurological disorders such as epilepsy, Alzheimer's disease,
- dementia, stroke, migraine and other headache disorders, multiple sclerosis,
- Parkinson's disease, neuroinfections, brain tumors and head trauma.
- Present or previous musculoskeletal disorders such as tendonitis, degenerative disc disease, mechanical back syndrome, and ruptured/herniated disc.
- Present or previous mental illnesses such as depression, bipolar disorder, and schizophrenia.
- Current use of medications that may affect the trial (e.g. analgesics, anti- inflammatories, anti-depressives)
- Contraindications to TMS application (history of epilepsy, metal implants in head or jaw, etc.)
- Failure to pass the tDCS screening questionnaire
- Failure to pass the "TASS questionnaire"
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Capsaicin - alone
5x7 cm2 capsaicin patch
|
5x7 cm2 capsaicin patch applied on the dorsal area of the hand and left in place for 24 hours
|
Placebo Comparator: Placebo - alone
5x7 cm2 placebo patch alone
|
5x7 cm2 patch applied on the dorsal area of the hand and left in place for 24 hours
|
Experimental: Capsaicin - ice
5x7 cm2 capsaicin patch - plus ice
|
5x7 cm2 capsaicin patch applied on the dorsal area of the hand and left in place for 24 hours.
Ice will be applied on top of the patch 1.5 hrs post patch application and left in place for 1 hr.
|
Placebo Comparator: Placebo - ice
5x7 cm2 placebo patch - plus ice
|
5x7 cm2 patch applied on the dorsal area of the hand and left in place for 24 hours.
Ice will be applied on top of the patch 1.5 hrs post patch application and left in place for 1 hr.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Conspiratorial excitability
Time Frame: [Time Frame: 0 minutes post homeostatic plasticity induction]
|
Corticospinal excitability measured as motor evoked potentials amplitude induced by transcranial magnetic stimulation.
|
[Time Frame: 0 minutes post homeostatic plasticity induction]
|
Conspiratorial excitability
Time Frame: [Time Frame: 15 minutes post homeostatic plasticity induction]
|
Corticospinal excitability measured as motor evoked potentials amplitude induced by transcranial magnetic stimulation.
|
[Time Frame: 15 minutes post homeostatic plasticity induction]
|
Conspiratorial excitability
Time Frame: [Time Frame: 30 minutes post homeostatic plasticity induction]
|
Corticospinal excitability measured as motor evoked potentials amplitude induced by transcranial magnetic stimulation.
|
[Time Frame: 30 minutes post homeostatic plasticity induction]
|
Conspiratorial excitability
Time Frame: [Time Frame: 45 minutes post homeostatic plasticity induction]
|
Corticospinal excitability measured as motor evoked potentials amplitude induced by transcranial magnetic stimulation.
|
[Time Frame: 45 minutes post homeostatic plasticity induction]
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain intensity
Time Frame: Every 10 minutes post capsaicin application
|
Pain intensity measured using an 11-point numeric rating scale where 0= no pain and 10 = worst imaginable pain.
|
Every 10 minutes post capsaicin application
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Rossini PM, Burke D, Chen R, Cohen LG, Daskalakis Z, Di Iorio R, Di Lazzaro V, Ferreri F, Fitzgerald PB, George MS, Hallett M, Lefaucheur JP, Langguth B, Matsumoto H, Miniussi C, Nitsche MA, Pascual-Leone A, Paulus W, Rossi S, Rothwell JC, Siebner HR, Ugawa Y, Walsh V, Ziemann U. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: Basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee. Clin Neurophysiol. 2015 Jun;126(6):1071-1107. doi: 10.1016/j.clinph.2015.02.001. Epub 2015 Feb 10.
- Fricke K, Seeber AA, Thirugnanasambandam N, Paulus W, Nitsche MA, Rothwell JC. Time course of the induction of homeostatic plasticity generated by repeated transcranial direct current stimulation of the human motor cortex. J Neurophysiol. 2011 Mar;105(3):1141-9. doi: 10.1152/jn.00608.2009. Epub 2010 Dec 22.
- Thapa T, Graven-Nielsen T, Chipchase LS, Schabrun SM. Disruption of cortical synaptic homeostasis in individuals with chronic low back pain. Clin Neurophysiol. 2018 May;129(5):1090-1096. doi: 10.1016/j.clinph.2018.01.060. Epub 2018 Feb 9.
- Thapa T, Schabrun SM. Test-Retest Reliability of Homeostatic Plasticity in the Human Primary Motor Cortex. Neural Plast. 2018 Jun 10;2018:6207508. doi: 10.1155/2018/6207508. eCollection 2018.
- Karabanov A, Ziemann U, Hamada M, George MS, Quartarone A, Classen J, Massimini M, Rothwell J, Siebner HR. Consensus Paper: Probing Homeostatic Plasticity of Human Cortex With Non-invasive Transcranial Brain Stimulation. Brain Stimul. 2015 May-Jun;8(3):442-54. doi: 10.1016/j.brs.2015.01.404. Epub 2015 Apr 1.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- N-20190069/2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Capsaicin Topical - alone
-
Aalborg UniversityRecruiting
-
Medical University of ViennaAstellas Pharma GmbHCompleted
-
Averitas Pharma, Inc.RecruitingPost Surgical Neuropathic PainUnited States, Spain, France, Netherlands, Poland, United Kingdom
-
Panag Pharma Inc.Completed
-
NHS Greater Glasgow and ClydeUnknownNeuropathic Pain | Arteriovenous FistulaeUnited Kingdom
-
Emma AitkenUnknownNeuropathic Pain | End Stage Renal FailureUnited Kingdom
-
NeurogesXCompleted
-
The University of Texas Health Science Center,...University of California, San FranciscoActive, not recruitingMigraine | Cluster Headache | Trigeminal Autonomic Cephalgia | Hemicrania Continua | Paroxysmal Hemicrania | SUNCT | Short-Lasting Unilateral Neuralgiform Headache With Conjunctival Injection and TearingUnited States
-
NHS Greater Glasgow and ClydeUnknownNeuropathic Pain | Lower Limb AmputationUnited Kingdom
-
Propella TherapeuticsPalm Beach Research, IncCompleted